Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Farrer, M; Chan, P; Chen, R; Tan, L; Lincoln, S; Hernandez, D; Forno, L; Gwinn-Hardy, K; Petrucelli, L; Hussey, J; Singleton, A; Tanner, C; Hardy, J; Langston, JW
   Lewy bodies and parkinsonism in families with parkin mutations
   ANNALS OF NEUROLOGY
   
   M. Farrer et al., "Lewy bodies and parkinsonism in families with parkin mutations", ANN NEUROL, 50(3), 2001, pp. 293-300
2. Morris, HR; Al-Sarraj, S; Schwab, C; Gwinn-Hardy, K; Perez-Tur, J; Wood, NW; Hardy, J; Lees, AJ; McGeer, PL; Daniel, SE; Steele, JC
   A clinical and pathological study of motor neurone disease on Guam
   BRAIN
   
   H.R. Morris et al., "A clinical and pathological study of motor neurone disease on Guam", BRAIN, 124, 2001, pp. 2215-2222
3. Gwinn-Hardy, K; Singleton, A; O'Suilleabhain, P; Boss, M; Nicholl, D; Adam, A; Hussey, J; Critchley, P; Hardy, J; Farrer, M
   Spinocerebellar ataxia type 3 phenotypically resembling Parkinson disease in a black family
   ARCHIVES OF NEUROLOGY
   
   K. Gwinn-Hardy et al., "Spinocerebellar ataxia type 3 phenotypically resembling Parkinson disease in a black family", ARCH NEUROL, 58(2), 2001, pp. 296-299
4. Lewis, J; McGowan, E; Rockwood, J; Melrose, H; Nacharaju, P; Van Slegtenhorst, M; Gwinn-Hardy, K; Murphy, MP; Baker, M; Yu, X; Duff, K; Hardy, J; Corral, A; Lin, WL; Yen, SH; Dickson, DW; Davies, P; Hutton, M
   Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
   NATURE GENETICS
   
   J. Lewis et al., "Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein", NAT GENET, 25(4), 2000, pp. 402-405
5. Evidente, VGH; Adler, CH; Caviness, JN; Hentz, JG; Gwinn-Hardy, K
   Amantadine is beneficial in restless legs syndrome
   MOVEMENT DISORDERS
   
   V.G.H. Evidente et al., "Amantadine is beneficial in restless legs syndrome", MOVEMENT D, 15(2), 2000, pp. 324-327
6. Caviness, JN; Gwinn-Hardy, K; Adler, CH; Muenter, MD
   Electrophysical observations in hereditary parkinsonism-dementia with Lewybody pathology
   MOVEMENT DISORDERS
   
   J.N. Caviness et al., "Electrophysical observations in hereditary parkinsonism-dementia with Lewybody pathology", MOVEMENT D, 15(1), 2000, pp. 140-145
7. Gwinn-Hardy, K; Chen, JY; Liu, HC; Liu, TY; Boss, M; Seltzer, W; Adam, A; Singleton, A; Koroshetz, W; Waters, C; Hardy, J; Farrer, M
   Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese
   NEUROLOGY
   
   K. Gwinn-Hardy et al., "Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese", NEUROLOGY, 55(6), 2000, pp. 800-805
8. Gwinn-Hardy, K; Mehta, ND; Farrer, M; Maraganore, D; Muenter, M; Yen, SH; Hardy, J; Dickson, DW
   Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p
   ACTA NEUROPATHOLOGICA
   
   K. Gwinn-Hardy et al., "Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p", ACT NEUROP, 99(6), 2000, pp. 663-672
9. Hardy, J; Gwinn-Hardy, K
   Neurodegenerative disease: a different view of diagnosis
   MOLECULAR MEDICINE TODAY
   
   J. Hardy e K. Gwinn-Hardy, "Neurodegenerative disease: a different view of diagnosis", MOL MED TOD, 5(12), 1999, pp. 514-517
10. Farrer, M; Gwinn-Hardy, K; Hutton, M; Hardy, J
    The genetics of disorders with synuclein pathology and parkinsonism
    HUMAN MOLECULAR GENETICS
    
    M. Farrer et al., "The genetics of disorders with synuclein pathology and parkinsonism", HUM MOL GEN, 8(10), 1999, pp. 1901-1905
11. Farrer, M; Gwinn-Hardy, K; Muenter, M; DeVrieze, FW; Crook, R; Perez-Tur, J; Lincoln, S; Maraganore, D; Adler, C; Newman, S; MacElwee, K; McCarthy, P; Miller, C; Waters, C; Hardy, J
    A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor
    HUMAN MOLECULAR GENETICS
    
    M. Farrer et al., "A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor", HUM MOL GEN, 8(1), 1999, pp. 81-85
12. Lincoln, S; Vaughan, J; Wood, N; Baker, M; Adamson, J; Gwinn-Hardy, K; Lynch, T; Hardy, J; Farrer, M
    Low frequency of pathogenic mutations in the ubiquitin carboxyterminal hydrolase gene in familial Parkinson's disease
    NEUROREPORT
    
    S. Lincoln et al., "Low frequency of pathogenic mutations in the ubiquitin carboxyterminal hydrolase gene in familial Parkinson's disease", NEUROREPORT, 10(2), 1999, pp. 427-429
13. Evidente, VGH; Gwinn-Hardy, K; Caviness, JN; Adler, CH
    Risperidone is effective in severe hemichorea/hemiballismus
    MOVEMENT DISORDERS
    
    V.G.H. Evidente et al., "Risperidone is effective in severe hemichorea/hemiballismus", MOVEMENT D, 14(2), 1999, pp. 377-379
14. Evidente, VGH; Adler, CH; Caviness, JN; Gwinn-Hardy, K
    A pilot study on the motor effects of rimantadine in Parkinson's disease
    CLINICAL NEUROPHARMACOLOGY
    
    V.G.H. Evidente et al., "A pilot study on the motor effects of rimantadine in Parkinson's disease", CLIN NEUROP, 22(1), 1999, pp. 30-32
15. Lincoln, S; Crook, R; Chartier-Harlin, MC; Gwinn-Hardy, K; Baker, M; Mouroux, V; Richard, F; Becquet, E; Amouyel, P; Destee, A; Hardy, J; Farrer, M
    No pathogenic mutations in the beta-synuclein gene in Parkinson's disease
    NEUROSCIENCE LETTERS
    
    S. Lincoln et al., "No pathogenic mutations in the beta-synuclein gene in Parkinson's disease", NEUROSCI L, 269(2), 1999, pp. 107-109
16. Lincoln, S; Gwinn-Hardy, K; Goudreau, J; Chartier-Harlin, MC; Baker, M; Mouroux, V; Richard, F; Destee, A; Becquet, E; Amouyel, P; Lynch, T; Hardy, J; Farrer, M
    No pathogenic mutations in the persyn gene in Parkinson's disease
    NEUROSCIENCE LETTERS
    
    S. Lincoln et al., "No pathogenic mutations in the persyn gene in Parkinson's disease", NEUROSCI L, 259(1), 1999, pp. 65-66
17. Gwinn-Hardy, K; Evidente, VGH; Waters, C; Muenter, MD; Hardy, J
    L-dopa slows the progression of familial parkinsonism
    LANCET
    
    K. Gwinn-Hardy et al., "L-dopa slows the progression of familial parkinsonism", LANCET, 353(9167), 1999, pp. 1850-1851